TAFFA N TMUSNIWIN TUSNANIN

Archived 47: Summary of National Advisory Committee on Immunization (NACI) updates of November 3, 2022: Recommendations on the use of Moderna Spikevax BA.4/5 bivalent mRNA (50 mcg) COVID-19 booster vaccine in adults

National Advisory Committee on ImmunizationAselkim2022Isemli yeḥrez

Agzul n yisemli ASEM

Official National Advisory Committee on Immunization document (2022) on “Archived 47: Summary of National Advisory Committee on Immunization (NACI) updates of November 3, 2022: Recommendations on the use of Moderna Spikevax BA.4/5 bivalent mRNA (50 mcg) COVID-19 booster vaccine in adults”. Summary of NACI updates on the use of Moderna Spikevax BA.4/5 bivalent mRNA COVID-19 booster vaccine in adults.

Agzul-a ad k-yefk tallalt deg unadi ɣef uttaft. I wellihen klinik, ẓer yal tikkelt lqem unṣib amiran akked uzemz n uleqqem-is.

Isemli unṣib